U.S. market Open. Closes in 3 hours 2 minutes

SEEL | Seelos Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.7400 - 0.9000
52 Week Range 0.6700 - 691.20
Beta 3.67
Implied Volatility 273.30%
IV Rank 91.13%
Day's Volume 7,904
Average Volume 566,091
Shares Outstanding 581,000
Market Cap 429,940
Sector Healthcare
Industry Biotechnology
IPO Date 1999-04-19
Valuation
Profitability
Growth
Health
P/E Ratio N/A
Forward P/E Ratio N/A
EPS 351.04
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 8
Country USA
Website SEEL
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in patients with major depressive disorders; SLS-005, a protein stabilizer for the treatment of amyotrophic lateral sclerosis and Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for the treatment of patients with Parkinson's disease (PD). Its preclinical programs include SLS-007, an anti-alpha-synuclein peptidic inhibitor to treat patients with PD; SLS-008, an orally available antagonist for chemoattractant receptor-homologous molecule for the treatment of chronic inflammation in asthma and pediatric orphan indications; SLS-004 for the treatment of PD; SLS-010, an oral histamine H3A receptor antagonist for narcolepsy and related disorders; and SLS-012, an injectable therapy for post-operative pain management. Seelos Therapeutics, Inc. was incorporated in 1987 and is headquartered in New York, New York.
SEEL's peers: ATAI, CYBN, MNMD
*Chart delayed
Analyzing fundamentals for SEEL we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is very wealthy, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see SEEL Fundamentals page.

Watching at SEEL technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on SEEL Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙